SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
160Well it's not at all clear to me that you would ever use the CIPH chip to peBiomaven-10/19/2003
159Further down the road, another competitive threat looms larger: nanosphere-inc.tuck-10/19/2003
158Of course, getting tissue samples from the lung is a lot less fun -- and more extuck-10/16/2003
157[identifying the proteins fingerprinted by SELDI] >>Anal Biochem. 2003 Octuck-10/9/2003
156>>Published online before print October 1, 2003 Proc. Natl. Acad. Sci. USAtuck-10/3/2003
155Researchers Believe Clinical Proteomics Promises Improved Disease Diagnosis ARLnigel bates-9/22/2003
154Also to the point - the-scientist.com <i>...But it is not certain yet thanigel bates-8/26/2003
153tuck, FWIW, there's a small Canadian company called Nymox that claims to haBiomaven-8/25/2003
152I recall that someone on your thread identified AD as a big and growing market. tuck-8/25/2003
151No mention of CIPH, but still relevant: <i>Mass Spectrometry and ProteomiBiomaven-8/25/2003
150And this, can't remember if this has been announced previously. Ciphergen Atom pope-8/19/2003
149Briefing: 09:10 ET CIPH Ciphergen Biosys initiated at TWP with Outperform antom pope-8/19/2003
148Here's one with hints regarding the monitoring of disease progression using tuck-8/19/2003
147To whit, from Mok's lab . . . >>Haptoglobin- Subunit As Potential tuck-8/19/2003
146Revenue a little light, but they affirm guidance. >>FREMONT, Calif., Julytuck-7/25/2003
145One of the themes over the last year or so has been combining different approachtuck-7/11/2003
144Some new AACR abstracts. Here's a couple that are a bit different from the tuck-7/3/2003
143>>Proteomics. 2003 Jun;3(6):957-61. Analysis of complex autoantibody retuck-7/3/2003
142Thanks, tuck. It is interesting to click on the other articles that have cited tBiomaven-7/2/2003
141This is old, but is the only free article I can find about the use of SELDI in dtuck-7/1/2003
140Good to see another deal in the wake of the settlement of the litigation: >&tuck-6/30/2003
139Ciphergen Announces Issuance of Key Patents for SELDI Technology and Protein Expnigel bates-6/27/2003
138<i> One peak significantly higher expressed in the tumor (p = 0.000029) waBiomaven-6/26/2003
137>>Mol Cell Proteomics. 2003 Jun 23 Biomarker discovery and identificatiotuck-6/26/2003
136Neurology 2003;60:1931-1937 © 2003 American Academy of Neurology MacrophaBiomaven-6/24/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):